Literature DB >> 16146482

Sublingual microcirculatory flow is impaired by the vasopressin-analogue terlipressin in a patient with catecholamine-resistant septic shock.

E C Boerma1, P H J van der Voort, C Ince.   

Abstract

For many decades arterial blood pressure regulation has been an important issue in the treatment of septic shock. The pathogenesis of this persistent hypotension is complex and multifactorial, but inability of vascular smooth muscle to contract in the presence of vasoconstrictive agents seems to be a key factor. Many mechanisms have been proposed to account for this failure, including nitric oxide (NO) overproduction and vasopressin deficiency (1). However, improvement of outcome due to intervention in these mechanisms fails to be reported despite the restoration of blood pressure. Recent studies of the microcirculation in humans by means of orthogonal polarization spectral (OPS) imaging have opened challenging new perspectives to study the microcirculation (2, 3). We report a case in which sublingual OPS imaging was performed upon administration of terlipressin in a patient with catecholamine-resistant septic shock. It indicates that much caution should be taken when considering such potent vasoconstrictor when correcting blood pressure during shock.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16146482     DOI: 10.1111/j.1399-6576.2005.00752.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  21 in total

1.  Vasopressin and splanchnic blood flow: vasoconstriction does not equal vasoconstriction in every organ.

Authors:  P Asfar; P Radermacher; B Hauser
Journal:  Intensive Care Med       Date:  2005-11-18       Impact factor: 17.440

2.  Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.

Authors:  Andrea Morelli; Abele Donati; Christian Ertmer; Sebastian Rehberg; Alessandra Orecchioni; Alessandro Di Russo; Paolo Pelaia; Paolo Pietropaoli; Martin Westphal
Journal:  Intensive Care Med       Date:  2011-02-19       Impact factor: 17.440

Review 3.  A global perspective on vasoactive agents in shock.

Authors:  Djillali Annane; Lamia Ouanes-Besbes; Daniel de Backer; Bin DU; Anthony C Gordon; Glenn Hernández; Keith M Olsen; Tiffany M Osborn; Sandra Peake; James A Russell; Sergio Zanotti Cavazzoni
Journal:  Intensive Care Med       Date:  2018-06-04       Impact factor: 17.440

Review 4.  Microcirculation: Physiology, Pathophysiology, and Clinical Application.

Authors:  Goksel Guven; Matthias P Hilty; Can Ince
Journal:  Blood Purif       Date:  2019-12-18       Impact factor: 2.614

5.  Hemodynamic coherence and the rationale for monitoring the microcirculation.

Authors:  Can Ince
Journal:  Crit Care       Date:  2015-12-18       Impact factor: 9.097

6.  Vasopressin in the pediatric cardiac intensive care unit: Myth or reality.

Authors:  Vishal K Singh; Rajesh Sharma; Amit Agrawal; Amit Varma
Journal:  Ann Pediatr Cardiol       Date:  2009-01

Review 7.  The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients.

Authors:  E Christiaan Boerma; Can Ince
Journal:  Intensive Care Med       Date:  2010-09-02       Impact factor: 17.440

8.  [Role of vasopressin in septic shock : critical evaluation].

Authors:  I Gradwohl-Matis; A Brunauer; D Dankl; M Dünser
Journal:  Anaesthesist       Date:  2014-06       Impact factor: 1.041

9.  Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study.

Authors:  Arnaldo Dubin; Mario O Pozo; Christian A Casabella; Fernando Pálizas; Gastón Murias; Miriam C Moseinco; Vanina S Kanoore Edul; Fernando Pálizas; Elisa Estenssoro; Can Ince
Journal:  Crit Care       Date:  2009-06-17       Impact factor: 9.097

Review 10.  Towards integrative physiological monitoring of the critically ill: from cardiovascular to microcirculatory and cellular function monitoring at the bedside.

Authors:  Abele Donati; Dick Tibboel; Can Ince
Journal:  Crit Care       Date:  2013-03-12       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.